The DEA announced three new proposed rules to make permanent certain telehealth flexibilities established during the pandemic, including a process for prescribing controlled substances without an in-person evaluation.
Strategist | strategy-catalyst
DEA proposes making telehealth prescribing flexibilities permanent, with strings attached
Related Topics:
Health Policy and Advocacy Relevant Roles:
Chief Strategy Officers